Diabetes Insights - Breakthroughs and Innovators

Tune in to our new podcast series, new episode released every Friday!

Join us for expert interviews and discussions on the latest advances in diabetes research. Discover how groundbreaking medicines and cutting-edge technologies are shaping the future of diabetes treatment and management.

Get inspired by the stories of distinguished researchers whose discoveries and contributions have transformed our understanding of diabetes.

These podcasts were recorded at the EASD Annual Meeting 2024 in Madrid, Spain. You can learn more about the research discussed by watching the scientific presentations in the EASD Media Centre.

Episode 2 features Matthias Blüher and Anette Ziegler, two leading experts in diabetes research, as they share their insights into the future of diabetes care by 2030.

The conversation explores innovative developments in the prevention and treatment of both Type 1 and Type 2 diabetes, with a focus on early diagnosis, immune interventions, and the potential of incretin-based therapies. Dr. Blüher discusses the exciting possibilities of personalised medicine and new pharmacotherapies, while Dr. Ziegler emphasizes the importance of primary prevention and the latest research into viral triggers.

This episode delves into the evolving landscape of diabetes care and the potential to revolutionise treatment options in the next decade.

Our first episode features Dr. Roy Taylor, a leading diabetes researcher and recipient of the prestigious EASD Claude Bernard Prize, discussing groundbreaking insights into type 2 diabetes remission.

He shares his journey in proving that type 2 diabetes can, in many cases, be reversed through targeted weight loss to reduce fat in the liver and pancreas. Dr. Taylor recounts the challenges he faced in gaining acceptance for his theories and highlights the role of media and patient stories in spreading awareness.

His approach has influenced a shift in treatment options, including the development of a national programme in the NHS for diabetes remission.